Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
02/2005
02/16/2005EP1506971A1 Prokineticin polypeptides, related compositions and methods
02/16/2005EP1506784A1 Identification of novel factors that block programmed cell death or apoptosis by targeting JNK
02/16/2005EP1506412A1 Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 2 (vpac2)
02/16/2005EP1506411A1 Method for identifying type-i interferon responsive ms patients by determining trail expression
02/16/2005EP1506408A2 Methods for diagnosing htlv-i-mediated diseases
02/16/2005EP1506398A2 Human secreted proteins
02/16/2005EP1506318A2 Methods and compositions for regulation and manipulation of steroidogenesis
02/16/2005EP1506317A2 Marker molecules associated with lung tumors
02/16/2005EP1506312A2 Metalloprotease peptide substrates and methods
02/16/2005EP1506306A2 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling
02/16/2005EP1506304A2 Nucleic acid-associated proteins
02/16/2005EP1506303A2 Enzymes
02/16/2005EP1506301A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
02/16/2005EP1506300A2 Genes and uses thereof to modulate secondary metabolite biosynthesis
02/16/2005EP1506299A2 Method for producing a transgenic plant having modified transport of substances
02/16/2005EP1506297A2 Brachyspira hyodysenteriae vaccine
02/16/2005EP1506296A1 A repressor-mediated regulation system for control of gene expression in plants
02/16/2005EP1506295A2 Muteins of placental growth factor type 1, preparation method and application thereof
02/16/2005EP1506288A2 Activation induced deaminase (aid)
02/16/2005EP1506234A1 Improved synthetic lipid mixtures for the preparation of a reconstituted surfactant
02/16/2005EP1506232A1 Sodium channel regulators and modulators
02/16/2005EP1506231A2 Hybrid and fusion polypeptide subunits of k+ channels
02/16/2005EP1506229A1 Obg3 fragments inhibiting the conversion of active obg3 into less active obg3 and other compositions for treatment of metabolic disorders
02/16/2005EP1506228A2 Role of p62 in aging-related disease
02/16/2005EP1506227A1 Methods for identifying and developing compounds that interact with voltage-gated potassium channels of the kv4 family
02/16/2005EP1506226A2 Use of the repressor glxr for the synthesis of lysine in corynebacterium glutamicum
02/16/2005EP1506225A2 Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis c virus
02/16/2005EP1506224A1 Polypeptide antigen inducing hiv neutralizing antibodies
02/16/2005EP1506223A1 Fusion protein of hiv regulatory/accessory proteins
02/16/2005EP1506222A2 Chimeric human papillomavirus 16 l1 proteins comprising an l2 peptide, virus-like particles prepared therefrom and a method for preparing the particles
02/16/2005EP1506219A2 Novel process for production of the somatostatin analog, octreotide
02/16/2005EP1506215A2 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
02/16/2005EP1506021A2 Novel use of adenoviruses and nucleic acids coding therefor
02/16/2005EP1506009A2 Glucan-based vaccines
02/16/2005EP1506003A1 Soluble formulations comprising insulin aspart and insulin detemir
02/16/2005EP1505882A1 Process for the isolation and purification of the glycoprotein avidin
02/16/2005EP1161548B1 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein
02/16/2005EP1157097A4 G protein-coupled receptor resembling galanin receptors
02/16/2005EP1093524B1 Recombinant herpes viruses for preparing recombinant adeno-associated viruses
02/16/2005EP0958376B1 Prolactin receptor gene as a genetic marker for increased litter size in pigs
02/16/2005EP0846160B1 Methods for enhancing the production of viral vaccines in cell culture by interferon suppression
02/16/2005EP0634896B1 Evaluation of patients with progressive immunosuppression
02/16/2005CN1582337A 丙型肝炎病毒疫苗 Hepatitis C Virus Vaccine
02/16/2005CN1582336A Moraxella (branhamella) catarrhalis antigens
02/16/2005CN1582335A Rice transposon genes
02/16/2005CN1582329A New biopesticide using gene from erwinia pyrifoliaeWT#3, novel pathogen that affects asian pear trees
02/16/2005CN1582302A Dermopharmaceutically and cosmetically active oligopeptides
02/16/2005CN1582301A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
02/16/2005CN1582299A Genes encoding for genetic stability, gene expression and gene of folding related proteins
02/16/2005CN1582298A High-level composing production for anthrax protection antigen
02/16/2005CN1582297A Hybrid and tandem expression of neisserial proteins
02/16/2005CN1582295A Novel epidermal growth factor protein and gene, and methods of use therefor
02/16/2005CN1582171A Pulmonary administration of chemically modified insulin
02/16/2005CN1582164A Antigen arrays for treatment of bone disease
02/16/2005CN1580264A High soluble expressed tricholsanthin mutant and its preparing method
02/16/2005CN1580082A Efficent polyethylene glycol activating process and activate use for protein modification
02/16/2005CN1580075A 11 segment human digestive tract tumoure blood vessel speicfic conjugated cyclopeptide GX series
02/16/2005CN1580074A Bean-potato antitumour protein
02/16/2005CN1580073A Human SARS virus surface film protein antigen determinant polypeptide, polynucleotide sequence and its use
02/16/2005CN1580072A SARS coronary virus nail protein high-immune-protosegment, coding sequence and its use
02/16/2005CN1189564C Modulators of the function of receptors of the TNF/NGF receptor family
02/16/2005CN1189482C Novel angiogenesis inhibitor
02/16/2005CN1189481C Human truncated recombination soluble TRAIL-170 protein and application for preparing tumour-curing medicine thereof
02/16/2005CN1189480C Overreationg factor as well as its preparation factor and gene
02/16/2005CN1189213C Tolerance to xenograft
02/16/2005CN1189211C Therapeutic methods and compsns. for treatment of in paired interpersonal and behavioral disorders
02/15/2005US6855873 Comprises nucleotide sequences coding bacterial protoxin protein for generating insect resistant plants
02/15/2005US6855872 Tolerance of trichothecene mycotoxins in plants through the modification of the ribosomal protein L3 gene
02/15/2005US6855866 Regulatory sequences which control RNA biosynthesis for evaluating embryogenesis in plants; tissue engineering and gene expression
02/15/2005US6855865 Nucleotide sequences coding cysteine-rich proteins for generation of disease/insect/fungal/nematode resistant dicots/monocots
02/15/2005US6855815 Introducing a nucleic acid to a host cell, growing host cell to express nucleic acid as a transcript and such transcript is expressed as a translation product containing cellular inhibitor of apoptosis protein
02/15/2005US6855814 For detection, diagnosis, prophylaxis and therapeutic tools to combat bacterial infections
02/15/2005US6855812 P-glycoproteins and uses thereof
02/15/2005US6855810 Ligands directed to the non-secretory component, non-stalk region of plgR and methods of use thereof
02/15/2005US6855809 Chimeric immunoglobulin for detecting hepatitis c viral (HVC) infections and/or contaminated blood products; diagnosis and viral diseases
02/15/2005US6855808 Prevent cell differentiation; culture product; genetic engineered protein
02/15/2005US6855807 Heterodimeric opioid G-protein coupled receptors
02/15/2005US6855806 Comprises secreted polypeptide for diagnosis and treatment of tumors, nervous system, reproductive and muscular disorder
02/15/2005US6855805 α-conotoxin peptides
02/15/2005US6855803 Protein having hemolytic activity and gene encoding the protein
02/15/2005US6855802 Mutated peptide compounds, derived from hsp70, useful in cancer immunotherapy
02/15/2005US6855801 Peptides modulating activities of heparin other glycosaminoglycans or proteoglycans
02/15/2005US6855693 Peptide for use in the treatment of cell damage caused by ischemia
02/15/2005US6855691 Methods for producing and using S-nitrosohemoglobins
02/15/2005US6855683 Hypersensitive response elicitor from Erwinia amylovora, its use, and encoding gene
02/15/2005US6855560 Detecting regulators of G-protein coupled receptor activity for treating nervous system, psychological, obesity and hypertensive disorders
02/15/2005US6855556 Binding protein as biosensors
02/15/2005US6855550 Genetically engineered microorganism for use as tools in the generation of heterologous binding proteins
02/15/2005US6855549 Methods and compositions for increasing the infectivity of gene transfer vectors
02/15/2005US6855546 Reducing binding of ubiquitin-proteasome system to cell surface receptor via peptide mimetics; for treating diabetes, glandular and muscle disorders
02/15/2005US6855544 Expressing heterologous polypeptide in eukaryotic tissue; tissue engineering
02/15/2005US6855543 Expression vector coding transmembrane region and an apoptosis inducing domain for treating cancer and/or autoimmune diseases; gene therapy
02/15/2005US6855533 Structure-based designed herbicide resistant products
02/15/2005US6855529 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
02/15/2005US6855520 Cell volume-regulated human kinase h-sgk
02/15/2005US6855519 Methods for enhancing the production of interferon in cell culture
02/15/2005US6855518 Anti-listeria bacteriocin
02/15/2005US6855517 Compositions and methods relating to breast specific genes and proteins
02/15/2005US6855516 Gene conferring lysozyme insensitivity to corynebacterium
02/15/2005US6855513 Quorum sensing signaling in bacteria